Lazard Asset Management’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.49M | Buy |
50,307
+4,901
| +11% | +$467K | 0.01% | 538 |
|
|
2025
Q4 | $3.68M | Buy |
45,406
+1,546
| +4% | +$133K | 0.01% | 651 |
|
|
2025
Q3 | $3.84M | Sell |
43,860
-1,902
| -4% | -$170K | 0.01% | 648 |
|
|
2025
Q2 | $3.8M | Buy |
45,762
+5,849
| +15% | +$489K | 0.01% | 815 |
|
|
2025
Q1 | $3.35M | Buy |
39,913
+37,795
| +1,784% | +$3.52M | 0.01% | 809 |
|
|
2024
Q4 | $194K | Sell |
2,118
-100
| -5% | -$9.62K | ﹤0.01% | 1619 |
|
|
2024
Q3 | $204K | Sell |
2,218
-3
| -0.1% | -$260 | ﹤0.01% | 1607 |
|
|
2024
Q2 | $182K | Buy |
2,221
+568
| +34% | +$41.7K | ﹤0.01% | 1589 |
|
|
2024
Q1 | $108K | Sell |
1,653
-78
| -5% | -$4.81K | ﹤0.01% | 1510 |
|
|
2023
Q4 | $98K | Sell |
1,731
-8,719
| -83% | -$457K | ﹤0.01% | 1661 |
|
|
2023
Q3 | $568K | Buy |
10,450
+1,822
| +21% | +$108K | ﹤0.01% | 1115 |
|
|
2023
Q2 | $579K | Buy |
+8,628
| New | +$526K | ﹤0.01% | 1088 |
|
|
2022
Q4 | – | Sell |
-1,026
| Closed | -$51K | – | 2493 |
|
|
2022
Q3 | $51K | Sell |
1,026
-1,537
| -60% | -$76.8K | ﹤0.01% | 1796 |
|
|
2022
Q2 | $116K | Buy |
2,563
+841
| +49% | +$37.6K | ﹤0.01% | 1462 |
|
|
2022
Q1 | $80K | Hold |
1,722
| – | – | ﹤0.01% | 1503 |
|
|
2021
Q4 | $86K | Buy |
1,722
+169
| +11% | +$8.74K | ﹤0.01% | 1498 |
|
|
2021
Q3 | $82K | Sell |
1,553
-88
| -5% | -$4.96K | ﹤0.01% | 1475 |
|
|
2021
Q2 | $100K | Hold |
1,641
| – | – | ﹤0.01% | 1342 |
|
|
2021
Q1 | $80K | Buy |
1,641
+459
| +39% | +$21.5K | ﹤0.01% | 1259 |
|
|
2020
Q4 | $47K | Buy |
+1,182
| New | +$42.2K | ﹤0.01% | 1411 |
|
|
2020
Q3 | – | Sell |
-1,884
| Closed | -$49K | – | 1679 |
|
|
2020
Q2 | $49K | Buy |
+1,884
| New | +$49.3K | ﹤0.01% | 1231 |
|
Other funds holding LMAT
CCA
VCM
CCM
CAM
GCM
VPM